US Stock MarketDetailed Quotes
NRSN NeuroSense Therapeutics
- 1.230
- -0.030-2.38%
Close Apr 26 16:00 ET
- 1.280
- +0.050+4.07%
Post 19:56 ET
22.86MMarket Cap-1481P/E (TTM)
1.285High1.170Low42.15KVolume1.240Open1.260Pre Close52.39KTurnover0.31%Turnover RatioLossP/E (Static)18.58MShares2.33052wk High-12.18P/B16.77MFloat Cap0.40052wk Low--Dividend TTM13.63MShs Float8.180Historical High--Div YieldTTM9.13%Amplitude0.400Historical Low1.243Avg Price1Lot Size
NeuroSense Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -62.76%2.64M | -62.76%2.64M | -43.64%4.76M | -31.67%7.09M | -67.89%4.41M | -35.91%7.09M | -35.91%7.09M | --8.44M | 943.66%10.37M | --13.74M |
| -Cash and cash equivalents | -25.49%2.64M | -25.49%2.64M | 7.89%4.76M | 63.00%7.09M | -84.44%1.36M | -67.97%3.54M | -67.97%3.54M | --4.41M | 337.53%4.35M | --8.74M |
| -Short-term investments | --0 | --0 | --0 | --0 | -38.99%3.05M | --3.55M | --3.55M | --4.03M | --6.03M | --5M |
| Receivables | 26.72%166K | 26.72%166K | -27.29%309K | -38.61%434K | 152.00%567K | -26.40%131K | -26.40%131K | --425K | 4,318.75%707K | --225K |
| -Other receivables | 26.72%166K | 26.72%166K | -27.29%309K | -38.61%434K | 152.00%567K | -26.40%131K | -26.40%131K | --425K | 4,318.75%707K | --225K |
| Prepaid assets | -43.55%70K | -43.55%70K | ---- | ---- | ---- | -6.06%124K | -6.06%124K | ---- | ---- | ---- |
| Restricted cash | 11.11%40K | 11.11%40K | 60.87%37K | 65.22%38K | -39.06%39K | -7.69%36K | -7.69%36K | --23K | --23K | --64K |
| Total current assets | -60.49%2.92M | -60.49%2.92M | -42.59%5.11M | -31.91%7.56M | -64.23%5.02M | -35.32%7.38M | -35.32%7.38M | --8.89M | 999.41%11.1M | --14.03M |
| Non current assets | ||||||||||
| Net PPE | -22.22%238K | -22.22%238K | -14.47%260K | -9.55%284K | -10.64%294K | 1,510.53%306K | 1,510.53%306K | --304K | 1,993.33%314K | --329K |
| -Gross PPE | -14.55%276K | -14.55%276K | -14.47%260K | -9.55%284K | -10.64%294K | 1,245.83%323K | 1,245.83%323K | --304K | --314K | --329K |
| -Accumulated depreciation | -123.53%-38K | -123.53%-38K | ---- | ---- | ---- | -240.00%-17K | -240.00%-17K | ---- | ---- | ---- |
| Other non current assets | -4.35%22K | -4.35%22K | -38.24%21K | -34.29%23K | --23K | --23K | --23K | --34K | -5.41%35K | ---- |
| Total non current assets | -20.97%260K | -20.97%260K | -16.86%281K | -12.03%307K | -3.65%317K | 1,631.58%329K | 1,631.58%329K | --338K | 571.15%349K | --329K |
| Total assets | -58.81%3.18M | -58.81%3.18M | -41.65%5.39M | -31.30%7.87M | -62.84%5.34M | -32.55%7.71M | -32.55%7.71M | --9.23M | 978.44%11.45M | --14.36M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 192.97%1.46M | 192.97%1.46M | 246.36%2.81M | 308.29%3.01M | 46.01%1.79M | 1,176.92%498K | 1,176.92%498K | --811K | 488.80%736K | --1.23M |
| -accounts payable | 192.97%1.46M | 192.97%1.46M | 343.20%913K | 808.33%1.09M | 132.78%419K | 1,176.92%498K | 1,176.92%498K | --206K | 900.00%120K | --180K |
| -Other payable | ---- | ---- | 213.39%1.9M | 210.88%1.92M | 31.11%1.37M | ---- | ---- | --605K | 445.13%616K | --1.05M |
| Current accrued expenses | 116.88%1.72M | 116.88%1.72M | ---- | ---- | ---- | 42.29%794K | 42.29%794K | ---- | ---- | ---- |
| Current debt and capital lease obligation | 7.81%69K | 7.81%69K | ---- | ---- | ---- | --64K | --64K | ---- | ---- | ---- |
| -Current capital lease obligation | 7.81%69K | 7.81%69K | ---- | ---- | ---- | --64K | --64K | ---- | ---- | ---- |
| Current liabilities | 100.41%3.46M | 100.41%3.46M | 246.36%2.81M | 308.29%3.01M | 46.01%1.79M | 189.11%1.73M | 189.11%1.73M | --811K | 488.80%736K | --1.23M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -50.34%73K | -50.34%73K | -51.45%84K | -45.26%104K | -39.13%126K | --147K | --147K | --173K | --190K | --207K |
| -Long term capital lease obligation | -50.34%73K | -50.34%73K | -51.45%84K | -45.26%104K | -39.13%126K | --147K | --147K | --173K | --190K | --207K |
| Derivative product liabilities | 596.33%1.52M | 596.33%1.52M | 572.25%2.69M | 812.30%6.3M | -35.42%527K | -88.07%218K | -88.07%218K | --400K | --691K | --816K |
| Total non current liabilities | 335.89%1.59M | 335.89%1.59M | 383.94%2.77M | 627.36%6.41M | -36.17%653K | -80.03%365K | -80.03%365K | --573K | --881K | --1.02M |
| Total liabilities | 141.51%5.05M | 141.51%5.05M | 303.32%5.58M | 482.13%9.41M | 8.66%2.45M | -13.77%2.09M | -13.77%2.09M | --1.38M | 1,193.60%1.62M | --2.25M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -54.27%-32.07M | -54.27%-32.07M | -65.09%-29.12M | -104.21%-29.9M | -121.08%-24.68M | -146.10%-20.79M | -146.10%-20.79M | ---17.64M | -96.35%-14.64M | ---11.16M |
| Paid-in capital | 14.34%30.19M | 14.34%30.19M | 13.49%28.92M | 15.84%28.36M | 18.47%27.56M | 51.30%26.41M | 51.30%26.41M | --25.48M | 191.61%24.48M | --23.27M |
| Total stockholders'equity | -133.35%-1.87M | -133.35%-1.87M | -102.50%-196K | -115.71%-1.55M | -76.14%2.89M | -37.61%5.62M | -37.61%5.62M | --7.85M | 949.73%9.84M | --12.11M |
| Total equity | -133.35%-1.87M | -133.35%-1.87M | -102.50%-196K | -115.71%-1.55M | -76.14%2.89M | -37.61%5.62M | -37.61%5.62M | --7.85M | 949.73%9.84M | --12.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg